FDBusiness.com

New Clinical Trial Backs Arla Foods Ingredients’ Infant Immunity Ingredient

 Breaking News
  • £3.7 Billion Worth of Discounts Disappear From UK Supermarket Shelves as Promotions Fall to Lowest Levels in 10 Years The pressure on UK retailers to be more transparent in their pricing has seen the number of trade promotions fall to their lowest levels for 10 years, and in 2017, shoppers will receive £3.7 billion less in promotional savings. This is according to a new report by IRI, the provider of big data and predictive analytics [...]...
  • Whisky, Tequila and Gin to Drive Global Spirits Category Growth to 2021 Just released data from the IWSR 2017-2021 Forecast suggests global volumes of whisky, gin and tequila are expected to make gains of 55.2m, 7.1m and 5.8m nine-litre cases respectively over the next five years, following their rapid growth in 2016. These categories together with baijiu (+48.2m cases between 2016 and 2021), will contribute the most in the [...]...
  • Huge Export Win to China For UK Food Producers A new export deal with China will bring a £200 million boost to the UK food industry and support 1,500 jobs. Taking advantage of the growing demand for UK and drink in China, seven new businesses in England and Northern Ireland have secured access to export pork – including three producers who, in a first [...]...
  • CSM Bakery Solutions Closes Sale of BakeMark Business CSM Bakery Solutions, a global leader in bakery ingredients, products and services, has completed the sale of its BakeMark business to private equity firm Pamplona Capital Management. The sale of BakeMark, which was announced mid-July, is an important element in CSM’s decision to focus on their core business in Europe and North America. “Completing the sale [...]...
  • Needham Coding Ireland to Show Own Brand ‘N’ Series CIJ Printers For the First Time Newly established business, County Westmeath-based Needham Coding Ireland Limited, which was formed following a merger between The Needham Group and long-standing Irish distributor, Advanced Coding Solutions (ACS), will be highlighting a wide range of continuous ink jet (CIJ), thermal ink jet (TIJ) and laser coding and marking equipment, and associated printer inks and makeup at [...]...
  • Mars Food Expands its Portfolio With Acquisition Mars Food, part of Mars Incorporated, is acquiring Preferred Brands International, a US-based, fully integrated manufacturer and marketer of all-natural, ready-to-heat Indian and Asian food products sold primarily under the Tasty Bite® brand. Tasty Bite’s® portfolio includes a wide range of vegetarian offerings, including Indian/Asian entrees, spice and simmer meal kits, and organic rice and [...]...

New Clinical Trial Backs Arla Foods Ingredients’ Infant Immunity Ingredient

February 06
10:33 2014

Feeding babies with infant formula enriched with Arla Foods Ingredients’ Lacprodan® OPN-10 supports their immune development, according to the results of a new trial.

Lacprodan® OPN-10 is made from the whey protein osteopontin, a bioactive component associated with the maturation of the infant immune system. Osteopontin is found in high concentrations in human milk – about 138mg per litre – but in much lower concentrations in bovine milk (about 15mg per litre). This means infants fed regular formula have a limited intake compared with their breastfed counterparts.

Researchers from China’s Fundan University Hospital and the University of California at Davis conducted a double-blind randomised clinical trial in which Chinese infants aged between one and six months were fed either regular infant formula or infant formula supplemented with Lacprodan® OPN-10, with both groups compared with a reference group of breastfed babies.

The results showed that the babies who were given infant formula supplemented with Lacprodan® OPN-10 experienced a similar number of days of fever to those fed breast milk, and a reduced number of days of fever compared with a control group fed ordinary infant formula. The study also demonstrated that Lacprodan® OPN-10 is safe for use in infant formula.

The findings from the as-yet unpublished study were presented last week by Professor Bo Lönnerdal of the University of California at Davis during the 2nd International Conference on Nutrition & Growth, which took place from 30 January to 1 February 2014 in Barcelona, Spain.

Lotte Neergaard Jacobsen, Nutrition Scientist atArla Foods Ingredients, said: “The development of Lacprodan® OPN-10 is part of the quest to create infant formula that is more like breast milk. The results from this clinical study show that we have moved a step closer to achieving this. Osteopontin in the form of Lacprodan® OPN-10 could be a significant missing link in creating infant formula that can deliver a similar level of immune protection to that offered by mother’s milk.”

Experts at Arla Foods Ingredients have developed and patented the purification of osteopontin from cows’ milk and its application in infant and follow-on formulas, making it possible to create products with the same concentration of osteopontin as breast milk.

About Author

colin

colin

Related Articles



Food & Drink Business Conference & Exhibition 2016

Upcoming Events

  • September 11, 2017drinktec
  • September 13, 2017FI Asia
  • September 19, 2017PROCESS EXPO 2017
  • September 22, 2017Global Summit on Food & Beverages
AEC v1.0.4

The Magazine

F&D Business Preferred Suppliers

Advertisements